VUZI Fundamental Analysis - VUZIX CORP

Name: VUZIX CORP (VUZI) Stock
Brand: VUZIX CORP
Rating: 6 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to VUZI. VUZI was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. VUZI has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, VUZI is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

VUZI had negative earnings in the past year.

In the past year VUZI has reported a negative cash flow from operations.

In the past 5 years VUZI always reported negative net income.

VUZI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -106.19%, VUZI is not doing good in the industry: 91.13% of the companies in the same industry are doing better.

VUZI has a Return On Equity of -115.71%. This is amonst the worse of the industry: VUZI underperforms 86.29% of its industry peers.

		Industry Rank	Sector Rank
ROA	-106.19%
ROE	-115.71%
ROIC	N/A

ROA(3y)-91.88%

ROA(5y)-68.19%

ROE(3y)-98.06%

ROE(5y)-72.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VUZI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VUZI does not have a ROIC to compare to the WACC, probably because it is not profitable.

VUZI has more shares outstanding than it did 1 year ago.

VUZI has more shares outstanding than it did 5 years ago.

There is no outstanding debt for VUZI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

VUZI has an Altman-Z score of 30.37. This indicates that VUZI is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 30.37, VUZI belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.

VUZI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	30.37

ROIC/WACCN/A

WACC9.21%

2.3 Liquidity

A Current Ratio of 7.68 indicates that VUZI has no problem at all paying its short term obligations.

VUZI has a better Current ratio (7.68) than 91.13% of its industry peers.

VUZI has a Quick Ratio of 6.59. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.

With an excellent Quick ratio value of 6.59, VUZI belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	7.68
Quick Ratio	6.59

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.77% over the past year.

VUZI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.75%.

The Revenue has been decreasing by -2.91% on average over the past years.

EPS 1Y (TTM)33.77%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%37.5%

Revenue 1Y (TTM)-12.75%

Revenue growth 3Y-24.1%

Revenue growth 5Y-2.91%

Sales Q2Q%18.62%

3.2 Future

The Earnings Per Share is expected to grow by 17.25% on average over the next years. This is quite good.

VUZI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.01% yearly.

EPS Next Y34.19%

EPS Next 2Y17.25%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year15.21%

Revenue Next 2Y44.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VUZI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VUZI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as VUZI's earnings are expected to grow with 17.25% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y17.25%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

VUZI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VUZIX CORP

NASDAQ:VUZI (11/5/2025, 3:43:53 PM)

3.075

-0.04 (-1.44%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)08-14 2025-08-14/amc

Earnings (Next)11-13 2025-11-13

Inst Owners31.17%

Inst Owner Change-0.13%

Ins Owners6.17%

Ins Owner Change1.83%

Market Cap237.82M

Revenue(TTM)5.53M

Net Income(TTM)-39185800

Analysts82.86

Price Target3.06 (-0.49%)

Short Float %20.36%

Short Ratio5.24

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)14.22%

Min EPS beat(2)10.13%

Max EPS beat(2)18.3%

EPS beat(4)2

Avg EPS beat(4)-4.17%

Min EPS beat(4)-30.72%

Max EPS beat(4)18.3%

EPS beat(8)2

Avg EPS beat(8)-24.1%

EPS beat(12)4

Avg EPS beat(12)-15.7%

EPS beat(16)4

Avg EPS beat(16)-19.37%

Revenue beat(2)1

Avg Revenue beat(2)-2.99%

Min Revenue beat(2)-21.97%

Max Revenue beat(2)15.99%

Revenue beat(4)1

Avg Revenue beat(4)-13.79%

Min Revenue beat(4)-30.92%

Max Revenue beat(4)15.99%

Revenue beat(8)1

Avg Revenue beat(8)-29.77%

Revenue beat(12)3

Avg Revenue beat(12)-20.76%

Revenue beat(16)3

Avg Revenue beat(16)-19.92%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)9.09%

EPS NY rev (1m)0%

EPS NY rev (3m)11.11%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-29.26%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-15.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	42.97
P/FCF	N/A
P/OCF	N/A
P/B	7.02
P/tB	7.94
EV/EBITDA	N/A

EPS(TTM)-0.51

EYN/A

EPS(NY)-0.39

Fwd EYN/A

FCF(TTM)-0.26

FCFYN/A

OCF(TTM)-0.23

OCFYN/A

SpS0.07

BVpS0.44

TBVpS0.39

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-106.19%
ROE	-115.71%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-91.88%

ROA(5y)-68.19%

ROE(3y)-98.06%

ROE(5y)-72.74%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.15

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	85.33%
Cap/Sales	41.88%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	7.68
Quick Ratio	6.59
Altman-Z	30.37

F-Score3

WACC9.21%

ROIC/WACCN/A

Cap/Depr(3y)371.21%

Cap/Depr(5y)276.01%

Cap/Sales(3y)109.82%

Cap/Sales(5y)75.83%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)33.77%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%37.5%

EPS Next Y34.19%

EPS Next 2Y17.25%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-12.75%

Revenue growth 3Y-24.1%

Revenue growth 5Y-2.91%

Sales Q2Q%18.62%

Revenue Next Year15.21%

Revenue Next 2Y44.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y21.43%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year62.45%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y58.02%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y31.45%

OCF growth 3YN/A

OCF growth 5YN/A

VUZIX CORP / VUZI FAQ

What is the ChartMill fundamental rating of VUZIX CORP (VUZI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to VUZI.

What is the valuation status of VUZIX CORP (VUZI) stock?

ChartMill assigns a valuation rating of 0 / 10 to VUZIX CORP (VUZI). This can be considered as Overvalued.

What is the profitability of VUZI stock?

VUZIX CORP (VUZI) has a profitability rating of 0 / 10.

How financially healthy is VUZIX CORP?

The financial health rating of VUZIX CORP (VUZI) is 8 / 10.

VUZIX CORP (VUZI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

VUZIX CORP / VUZI FAQ

What is the ChartMill fundamental rating of VUZIX CORP (VUZI) stock?

What is the valuation status of VUZIX CORP (VUZI) stock?

What is the profitability of VUZI stock?

How financially healthy is VUZIX CORP?